ABSTRACT Background: Chronic low-grade inflammation is a likely intermediary between quality of carbohydrate and chronic disease risk. Objective: We conducted a systematic literature search to evaluate the relevance of carbohydrate quality on inflammatory markers in observational and intervention studies.
INTRODUCTION
Chronic, low-grade inflammation is now considered to be intimately linked to the development of diabetes (1) and cardiovascular disease (CVD) 4 (2) . In addition, subclinical activation of the immune system has been found to be associated with a range of other diseases, such as dementia (3), depressive disorders (4) , and certain types of cancer (5) . Finally, low-grade inflammation is associated with a higher risk of all-cause mortality in old age (6) . Thus, modifiable risk factors that effectively reduce chronic inflammation can be expected to contribute substantially to the prevention of chronic disease.
In this context, different aspects characterizing carbohydrate quality have recently received considerable interest. Dietary fiber intake is considered to reduce chronic inflammation by decreasing lipid oxidation (7) and beneficially interacting with gut microflora via regulatory influences of short-chain fatty acids produced from colonic fermentation of fiber (8) . Whole-grain foods are additionally rich in several bioactive compounds with antiinflammatory properties, such as free radical scavenging, antioxidant enzyme activation, or modification of the redox status of tissues and cells (7) . In addition, viscous fiber from oats or barley may slow the rates of glucose appearance in the blood (9) . Postprandial glycemic response to a food is best captured by the glycemic index (GI, a ranking of carbohydrate foods by their glycemic potency) (10) and the glycemic load (GL, defined as the mathematical product of the GI and carbohydrate content) (11) . Excessive postprandial blood glucose excursions are considered to yield nitric oxide generation, which in turn combines with superoxide to produce peroxynitrite-a potent long-lived pro-oxidant molecule (12) . Hence, consumption of high-GI foods may contribute to oxidative stress and both acute and chronic low-grade inflammation (13) .
These potential effects of carbohydrate quality on chronic inflammation have recently been investigated in many observational and interventional studies. Comparative assessment of the evidence from these 2 types of studies may be particularly insightful because evidence appraisal on the relevance of carbohydrate quality for chronic diseases (eg, type 2 diabetes, CVD, cancer) almost exclusively draws on observational studies. Thus, the aim of the current systematic review was to evaluate the evidence from currently published observational and interventional studies conducted in adults who were either healthy, were overweight, or had features of the metabolic syndrome or type 2 diabetes regarding the relevance of fiber intake, whole-grain consumption, and dietary GI/GL for markers of chronic lowgrade inflammation. We selected high-sensitivity C-reactive protein (hsCRP) and IL-6 because they represent the most commonly measured immune mediators in clinical and epidemiologic studies. Currently, there is more evidence that IL-6 is causal for the development of inflammation-related diseases such as CVD (14, 15) , whereas C-reactive protein (CRP) concentrations may be a "bystander" rather than a true risk factor. However, CRP has been frequently measured in studies with robust associations with many health outcomes and is therefore a useful prognostic biomarker.
SUBJECTS AND METHODS

Study selection
We conducted a systematic literature search of the MEDLINE (http://www.ncbi.nlm.nih.gov/pubmed/), EMBASE (http://www. elsevier.com/online-tools/embase), and Cochrane Library [Cochrane Central Register of Controlled Trials (CENTRAL); http:// onlinelibrary.wiley.com/cochranelibrary/search/] databases from January 1990 through September 2012 (updated June 2013). The search was limited to this time frame because hsCRP assays were first available in the early 1990s. The following terms were used to identify all potentially relevant publications published as conference abstracts or complete manuscripts in the English or German language: glyc(a)emic index/load, whole grain(s), fiber/ fiber, carbohydrate quality together with (hs-) CRP, (highsensitivity) C-reactive protein, IL-6, and interleukin 6 (see "Supplemental data" in the online issue). The search was restricted to human studies carried out in adults ($18 y). Inclusion criteria for epidemiologic studies (cross-sectional or prospective cohort studies) were as follows: dietary GI, GL, whole grain or dietary fiber intake as a predictor, hsCRP, or IL-6 among the outcomes and information on the dietary assessment method. Inclusion criteria for intervention studies were as follows: a randomized controlled or a crossover design, information on adherence to the intervention diets, and data on changes in BMI or body weight.
Because we were interested in the specific effects of GI/GL, whole grain, or fiber on low-grade inflammation, we excluded studies that analyzed dietary patterns, treatment studies, or studies on pregnant women. To this end, we excluded intervention studies on participants with inflammatory diseases other than type 2 diabetes or the metabolic syndrome at baseline, ie, diseases such as arthritis, pneumonia, or Alzheimer disease for which inflammation or oxidative stress represent relevant components in their development and/or progression.
Furthermore, studies lasting ,3 wk or including ,20 participants (10 individuals per treatment group) were not considered to provide sufficient information for the research questions under investigation. The literature search was conducted independently by 3 investigators (JG, GJ, and AF). The identification process is illustrated in Figure 1 . In addition, a manual search of references cited by the published original studies and relevant review articles was performed (cross-references). This systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (16) .
Data extraction
Two investigators (JG and AF) independently reviewed and extracted relevant data from each report. Any disagreement between reviewers was resolved by consensus and if necessary referred to the senior researcher (AEB). Extracted data included information on study design, duration, location, sample size, participant characteristics (sex, age, BMI, health status), nutritional assessment, type of intervention (eg, dietary counseling or provision of foods) and weight maintenance or loss, GI, GL, whole grain and/or fiber intakes, and adjustments for potentially confounding factors (see Supplemental Tables 1-4 under "Supplemental data" in the online issue). For studies that provided data on GL and carbohydrate intake only, the dietary GI was calculated [GI = GL/carbohydrate (in g) 3 100]. GI values referring to white bread as the reference food (= 100) (17) (18) (19) (20) (21) were transformed to the glucose scale by dividing the respective GI and GL values by 1.4286 (22) . Data on hsCRP and IL-6 were extracted as the inflammatory markers of interest. We extracted data from baseline and change and/or endpoint of these outcome measurements. Where available, results from intention-to-treat analyses are reported to reduce attrition bias.
RESULTS
The study selection process is shown in Figure 1 . Of the 970 reports identified by the search, 864 were excluded based on title and abstract. The remaining 106 reports were reviewed in full, which led to the exclusion of a further 49 reports. The literature update conducted in June 2013 revealed 3 more eligible studies. Of the 60 studies included in the systematic review, 22 addressed dietary GI or GL, 27 fiber, and 14 whole grain intake. Qi et al (23) addressed all 3 aspects of carbohydrate quality considered in this review, and Murakami et al (24) examined both dietary GI/GL and dietary fiber intake.
Dietary GI and GL
Epidemiologic studies
Nine epidemiologic studies were identified that addressed dietary GI and/or GL as a nutritional exposure variable (17) (18) (19) (23) (24) (25) (26) (27) (28) (Table 1) . Overall, the studies included 26,131 participants (range: 171-18,137) aged 20-67 y with a BMI (in kg/m 2 ) ranging from 21 to 30. Four of the studies included women only (19, 23, 24, 27) . Dietary GI ranged from 52 to 71 and dietary GL from 96 to 179 g, mostly assessed by means of a food-frequency questionnaire (FFQ) (n = 7 studies). Details on population, assessment method, average baseline concentrations of exposures, and covariates considered in the analysis and results are shown elsewhere (see Supplemental Table 1 under "Supplemental data" in the online issue).
One cross-sectional study among 244 healthy US women reported a strong association with hsCRP for both dietary GI and GL (19) . Similarly, in a subsample of 974 Dutch participants drawn from 2 population-based cohorts, higher concentrations of GI and GL tended to be related to higher concentrations of hsCRP (P = 0.05 and P = 0.09, respectively) (26). Three cross-sectional studies reported associations confined to either GI or GL: in .18,000 postmenopausal US women (27) and a sample of 891 US women with type 2 diabetes (23), a higher dietary GI, but not a higher dietary GL, was related to increased hsCRP concentrations. Conversely, in a subsample of 4366 Dutch participants drawn from a population-based cohort, a direct association was seen for dietary GL only (28) . In two 1-y prospective studies among 511 Spanish participants at high CVD risk (25) and 582 healthy Americans (17) , indications of a cross-sectional association between GI and IL-6 (25) or GL and hsCRP (17) were not confirmed in longitudinal analyses. Finally, 2 studies conducted in 136 overweight Americans (18) , and 443 healthy young Japanese women (24) found no associations between dietary GI or GL and hsCRP (Table 1) .
Intervention studies
Thirteen intervention studies met all the inclusion criteria (20, 21, (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (Table 2 ). The included studies lasted 4-52 wk and included a total of 2237 participants (range: 15-932) aged 30-66 ywith a BMI ranging from 28 to 36. Two studies included male participants only (32, 37) . The dietary GI (estimated from 10 studies) in the intervention (low-GI or GL) and control (high-GI or GL) groups ranged from 33 to 57 and 58 to 86, respectively, and the corresponding dietary GL ranges (estimated from 11 studies) were 36-158 and 68-250 g, respectively. Three studies were designed as weight-loss trials (21, 30, 36) , and 2 additional studies offered advice on weight loss if desired (20, 39) , but weight changes were similar in the intervention and control groups. Details on participant characteristics, dietary interventions, primary endpoints, and the analysis and results are shown elsewhere (see Supplemental Table 2 under "Supplemental data" in the online issue).
Three GI/GL intervention studies reported that reductions in hsCRP (21, 31) or IL-6 (34) in the low-GI/GL group were significantly larger than changes in the control group. In the Diet, Obesity and Genes study, conducted in 932 overweight participants from 8 European countries, groups assigned to a low-GI diet had notably larger reductions in hsCRP concentrations after the 26-wk weight-maintenance period than did those assigned to a high-GI diet (31), whereas a higher protein intake significantly increased hsCRP. Two smaller intervention studies including obese persons reported larger reductions in IL-6 in response to a low-GI diet (34) and larger reductions in hsCRP in response to a low-GL diet (21) when compared with changes under a high-GI or low-fat control diet, respectively. In 4 further studies, overall changes were not significantly different between the treatment groups. However, results suggested a treatment effect because the authors reported a trend for a between-group difference of change (29) or a treatment effect (35) , a pronounced reduction in the low-GL study arm only (36, 39) , or a between-group difference of change confined to participants with high body fat mass (35) . In 6 further studies, lasting 4-40 wk, low-GI/GL diets did not result in larger reductions in hsCRP concentrations (20, 30, 32, 33, 37, 38) or IL-6 (37, 38) in comparison with reductions observed under various control diets with a higher GI and GL (Table 2) .
Dietary fiber
Epidemiologic studies
In total, 16 epidemiologic studies were identified that reported on the association between dietary fiber intake and hsCRP or IL-6 (23, 24, 40-53) ( Table 3 , top). Overall, these studies included 39,893 participants (range: 87-9895) aged 20-69 y (data from 12 studies) and a BMI of 21-31 (data from 12 studies). Three studies included women only (23, 24, 51) ; one study was performed in men only (53) . Dietary fiber intake was assessed through an FFQ (n = 8 studies), 24-h recalls (n = 5 studies), or other methods (n = 3), and the studies varied notably in the presentation of dietary fiber intake data (see Supplemental Table  3 under "Supplemental data" in the online issue).
Overall, 13 of these 16 studies reported an inverse association between the intake of dietary fiber and concentrations of hsCRP (23, 40-42, 45, 47-50, 53) or IL-6 (43, 46, 51, 53) . Of note, inverse associations with these markers were also seen in longitudinal analyses of 4 studies including healthy individuals (51), persons with a metabolic syndrome (41) , and CVD risk factors or type 2 diabetes (45, 46), who were followed up after 3 mo (45) or 1 y (41, 46, 51) . In 3 further cross-sectional studies including ,2000 participants, dietary fiber intake was not related to hsCRP concentrations (24, 44, 52) (Table 3, 
top).
Intervention studies
Eleven intervention studies addressing the effect of dietary fiber intake or fiber supplements on hsCRP and/or IL-6 were identified (60-70) ( Table 4 , top). These studies lasted 3-16 wk and included a total of 690 participants (12-166) aged 38-63 y with a BMI range from 25 to 34 (data from 10 studies). One study was performed in men only (70) . In most of the studies, fiber supplements were added to the habitual diet (61, 63, (66) (67) (68) (69) (70) , 2 used special fiber-enriched study foods (60, 62) , and 1 study compared a high-fiber Dietary Approaches to Stop Hypertension (DASH) diet and a fiber-supplemented diet (65) . Four studies reported the fiber dose of the administered supplements only (63, (68) (69) (70) . Overall, information on fiber intake differed notably, precluding the calculation of mean intakes. Three of the studies were designed as weight-loss trials (63, 69, 70) , but a trend toward a greater BMI reduction in the intervention group was observed in one study only (63) (see Supplemental Table 4 under "Supplemental data" in the online issue).
In one crossover trial examining participants with mild hypercholesterolemia, hsCRP but not IL-6 concentrations were reduced to a larger extent in the 5-wk high-fiber period when compared with the low-fiber period (64) . In a 3-wk randomized crossover study among w: no association with GI or GL.
3
Estimated from values given per quantiles. Effect or no effect of intervention 2: no effect of dietary intervention on hsCRP or IL-6.
4
Weighted mean value calculated from baseline concentrations for treatment groups. See "Supplemental data" in the online issue for baseline concentrations in the treatment groups.
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Denmark, the Netherlands, the United Kingdom, Greece (Crete), Germany, Spain, Bulgaria, and the Czech Republic.
35 healthy, obese, or hypertensive participants, an hsCRP reduction tended to be more pronounced under the high-fiber-supplemented diet when compared with the high-fiber DASH diet (P-treatment effect = 0.09) (59) . In none of the other included intervention studies did the fiber supplementation or the fiber-enriched study foods result in greater reductions of hsCRP or IL-6 when compared with changes under the control diets (60) (61) (62) (63) (66) (67) (68) (69) (70) (Table 4 , top). Strictly speaking, the intervention by Jenkins et al (20) also constitutes a fiber-intervention study. However, because fiber intake was higher in the low-GI control diet group than in the high-cereal-fiber diet group, this study was reviewed in the GI/GL section only.
Whole grain
Epidemiologic studies
Seven observational studies were identified reporting on the association between whole grain intake and hsCRP and/or IL-6 (23, 54-59) (Table 3, bottom) . The overall number of participants in these studies was 11,295 (259-5496); they were aged 27-62 y and had a BMI of 24-31. Two of the studies included women only (23, 54) . Definition and assessment of whole grain intake, mostly by means of an FFQ (n = 6 studies), differed notably across the studies (see Supplemental Table 3 under "Supplemental data" in the online issue).
Five studies observed a significant association between a higher whole-grain consumption and lower hsCRP or IL-6 concentrations (23, 54, 56-59), and one study reported only a trend for the relation between whole grain and hsCRP (56) . In 2 further studies, whole-grain intake was not related to hsCRP or IL-6 concentrations (55) . Of note, whole-grain intake appeared to be of specific relevance for inflammatory markers among persons with type 2 diabetes (23, 57) (Table 3, bottom).
Intervention studies
Seven studies were identified that examined the effect of wholegrain intake on hsCRP or IL-6 concentrations (71-77) ( Table 4 , bottom). The duration of these intervention studies ranged from 3 to 16 wk. Studies included a total of 742 participants (15-266) aged 46-60 y with a BMI range of 27 to 36. One study included only women (76) . Two studies were designed as weight-loss trials (75, 76) . Although weight loss did not differ between the groups, one study observed a greater loss in percentage body fat in the intervention group (whole-wheat group) (76) . Definition and assessment of whole-grain intake was again notably different between the studies (see Supplemental Table 4 under "Supplemental data" in the online issue).
In one study (75) based on 50 obese individuals with the metabolic syndrome, who were instructed to either avoid whole grains or to consume all grains by means of whole grains, significantly larger reductions in hsCRP were observed with the whole-grain treatment. In a further study, significant improvements in hsCRP in response to a whole-grain diet when compared with changes under a control diet were confined to patients not using statins (73) . In addition, in a trial among 72 overweight postmenopausal women, increases in IL-6 concentrations were more pronounced in the whole-wheat group than in the refined-wheat food group, whereas hsCRP concentrations were unaffected (76) . The remainder of 4 studies, in which whole-grain foods were provided, did not observe a treatment effect on hsCRP or IL-6 concentrations (71, 72, 74, 77) (Table 4 , bottom).
Qualitative comparison did not provide an indication that sex, age, or health status of the study population influenced the results of the 31 intervention studies identified in this systematic review.
DISCUSSION
The current systematic review identified 29 observational studies that addressed the relevance of dietary GI/GL, fiber, and whole grain to chronic low-grade inflammation as assessed by hsCRP or IL-6. The observational studies addressing dietary fiber or whole-grain intake almost unanimously suggest a benefit of a higher consumption on low-grade inflammation, whereas evidence is less consistent for a beneficial role of a lower GI or GL. However, considering the evidence from 31 intervention studies, a different picture emerges because most of the intervention studies do not report a benefit of increasing fiber or whole-grain intake for lowgrade inflammation, whereas several intervention studies do support a potential role of dietary GI or GL.
The current review shows considerable heterogeneity among observational studies regarding associations between dietary GI/ GL and markers of chronic inflammation. This is in line with the heterogeneity reported for observational studies linking GI/GL to chronic disease outcomes such as type 2 diabetes (78, 79) and CVD (80) (81) (82) (83) . A recent meta-analysis of the association between dietary GL and the development of type 2 diabetes showed that this heterogeneity was almost exclusively attributable to differences in the studies regarding sex, ethnicity, and the ability of the FFQ to correctly measure carbohydrate consumption (79) . In the current review, 2 of the 4 studies reporting no associations had used an FFQ for which correlation coefficients with dietary records were ,0.6 for total carbohydrate intake (24, 25) (see Supplemental Table 1 under "Supplemental data" in the online issue). The calculation of dietary GL and GI is based on data for total carbohydrate intake, which results in an insufficient estimation of dietary GI and GL. Additional methodologic limitations when estimating dietary GI and GL from FFQs include entry of low and high-GI foods into the same food grouping (eg, whole-kernel and whole-meal breads, respectively), assignment of GI values available for similar foods, and interresearcher variation in GI assignment (84) . Of note, epidemiologic studies on dietary GI/GL are, however, not as amenable to residual confounding, because dietary GI/GL does not strongly correlate with healthy lifestyle behaviors given that most populations are still largely unaware of what constitutes a low dietary GI (85) .
In line with evidence from observational studies, intervention studies provided some support for the relevance of the GI/GL concept on chronic inflammation. Associations were most evident in the largest (31) study, which used a low-GI diet rather than a low-GL diet, ie, diets that modified the quality of the consumed carbohydrates only. It is plausible that such a dietary approach would be most effective regarding the reduction of chronic inflammation because the avoidance of glycemic spikes is considered to be of primary relevance for oxidative stress, and this is well captured by the dietary GI in diets with at least a moderate to high carbohydrate content (86) . In contrast, a lower carbohydrate intake may be associated with increased energy intake from protein and saturated fat, which might in turn be expected to increase See "Supplemental data" in the online issue for details on population, assessment method, average baseline concentrations of exposures, and covariates considered in the analysis and results. *Average value (mean or median as provided in the original publication). Cross, cross-sectional; CHD, coronary heart disease; CRP, C-reactive protein; EPIC, European Prospective Investigation into Cancer and Nutrition; FFQ, food-frequency questionnaire; fib, dietary fiber intake; hsCRP, high-sensitivity C-reactive protein; IGT, impaired glucose tolerance; prosp, prospective; T2D, type 2 diabetes mellitus; WG, whole grain.
2 w: no association with fiber or whole grains; Y: inverse association with fiber or whole grains; (Y): trend for inverse association with fiber or whole grains.
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TABLE 4
Fiber and whole grain and hsCRP and IL-6: intervention studies Effect or no effect of intervention Effect or no effect of intervention Whole wheat: -CRP,
2IL-6
1 See "Supplemental data" in the online issue for details on participant characteristics, dietary interventions, primary endpoints, analysis, and results. *Average value (mean or median as provided in the original publication). CRP, C-reactive protein; CVD, cardiovascular disease; DASH, Dietary Approaches to Stop Hypertension; hsCRP, high-sensitivity C-reactive protein; RCT, randomized controlled trial; T2D, type 2 diabetes mellitus; WG, whole grain.
2 P values of between-group differences for changes in inflammatory markers are reported for RCTs; P values for treatment effects are reported for crossover trials. 2: no effect of dietary intervention on hsCRP or IL-6.
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inflammation (31) . In line with this, the study by Ebbeling et al (29) observed the lowest hsCRP concentrations in the low-GI diet arm and higher hsCRP concentrations in the very low carbohydrate arm.
The current review identified a substantial discrepancy between observational and interventional studies with respect to the evidence from these studies linking fiber or whole grain intake to chronic lowgrade inflammation. Similar discrepancies were previously reported (87) and appear to extend also to the preventive potential of wholegrain intake in the management of body weight (88) . This may to some extent reflect the fact that relative differences in fiber or wholegrain intakes between the extreme quantiles in observational studies notably exceed relative differences commonly realized between treatment arms in intervention studies (see Supplemental Tables 3  and 4 under "Supplemental data" in the online issue). Alternatively, this discrepancy may arise from considerable confounding or from substantial methodologic limitations of the intervention studies.
It is well known that a higher fiber or whole-grain intake correlates notably with other aspects characterizing a healthier lifestyle (89) , and it is very likely that observational studies only partly account for residual confounding because the assessed variables describing lifestyle may not reflect all relevant aspects (unmeasured confounding). Hence, observational studies may substantially overestimate the "true" beneficial effect of fiber or whole-grain intakes on low-grade inflammation.
Similarly, residual confounding may operate in observational studies linking higher fiber or whole-grain intakes to reduced risks of type 2 diabetes and CVD (90) (91) (92) (93) (94) , because these associations are considered to be partly mediated by chronic lowgrade inflammation (95) . Hence, effective increases in whole grain or fiber intakes may not yield the health benefits currently expected based on observational evidence only. The fact that high-fiber diets were effectively used in landmark diabetes prevention studies (96, 97) does not contradict this concern, because the benefits observed in these studies stem from weight loss via integrated lifestyle modifications and cannot be directly attributed to the composition of the diet.
Concerning the intervention studies identified in this systematic review, note that most of them included ,100 participants and were not designed to address chronic low-grade inflammation as a primary outcome (see Supplemental Tables 2-4 under "Supplemental data" in the online issue). Because most intervention studies may not have been sufficiently powered to detect smaller effects with statistical significance, our evidence appraisal also considered results suggestive of treatment effects (ie, trends) and/or effects in subgroups only. In addition, it could be argued that the included participants were too young or too healthy or that the time period covered by the intervention studies was too short for a beneficial effect on the inflammatory markers to establish. However, to address this concern we considered only studies lasting $3 wk, and qualitative comparisons did not suggest a link of effectiveness to age, health status of the participants, or study duration. Although weightloss trials mostly observed comparable weight loss in both study arms, minor between-group differences in energy intake and hence minor differences in adiposity changes may nonetheless have confounded the findings. Moreover, some studies did not provide foods, but gave advice only. Generally, it is possible that the foods provided or selected were foods rich in dietary fiber or whole grain, yet had a high dietary GI because many wholegrain foods or foods rich in dietary fiber are characterized by a high dietary GI (eg, whole-meal breads or instant porridge oats). Beneficial components of high-fiber or whole-grain foods contributing to reduced chronic inflammation may have been counteracted by the higher postprandial glycemic excursions that these foods provoke. In this context, it is of interest that approaches directed at lowering the dietary GI appear to entail both a lower dietary GI and a higher dietary fiber intake, as evident in the study by Jenkins et al (20) . Therefore, larger intervention studies using combinations of increases in wholegrain and fiber intakes and reductions in dietary GI/GL are needed to determine optimal dietary approaches to reduce chronic inflammation. The magnitude of differences observed in the studies reporting significant findings [with relative betweengroup differences of change ranging from 16% (31) to w40% (21, 64, 75) ] supports the notion that such an approach can indeed yield clinically relevant findings.
Finally, CRP, although closely associated with the development of chronic diseases, may not be a causal risk factor, and the assays of both CRP and IL-6 are poorly standardized. Considerable variation for average concentrations of CRP and IL-6, which are most likely attributable to the type of assay, are shown in Tables 1-4 . Whereas this should, in principle, not affect the effect sizes or estimates of intervention effects, it cannot be excluded that some assays may have been more precise than others [eg, interassay CVs ranged between 1.0% (42) and 10.8% (18) for CRP and reached up to 30.7% for IL-6 (43)], which could have led to an underestimation of associations in epidemiologic studies and of effects in intervention trials. We excluded studies that reported to be conducted in participants who had inflammatory diseases at baseline, but refrained from excluding studies on the basis of initial CRP concentrations alone because these may have depended more strongly on the type of assay than the participants' baseline status of acute or chronic inflammation. However, note that the diseases included in this review, such as diabetes or obesity, are also characterized by a proinflammatory component, precluding a strict exclusion of inflammatory diseases.
The strengths of this systematic review include its approach to consider the totality of evidence currently available from both observational and intervention studies for 3 major aspects of carbohydrate quality. Mechanisms discussed to link these carbohydrate quality measures to chronic inflammation show only some overlap, which justifies a separate consideration. Quantification of the observed associations would have been desirable; however, in our view, the data are too heterogeneous to justify a meta-analysis. In particular, the intervention studies differ notably in their design: the degree to which foods were provided, the use of supplements or dietary fiber, the definitions of wholegrain foods, and the broad variety of diets used as control diets. In view of this heterogeneity, the overall number of identified studies covering 3 aspects of carbohydrate quality and 2 study types is still considerably small. As larger intervention studies and prospective observational studies become available, future systematic reviews might be able to perform meta-analyses.
In conclusion, evidence from intervention studies for antiinflammatory benefits is less consistent for higher-fiber or wholegrain diets than for low-GI/GL diets. Antiinflammatory benefits of higher dietary fiber and whole grain intakes suggested by observational studies are not supported by intervention studies, which indicates that confounding is likely and/or that the statistical power in intervention studies may have been too low to reveal small effects.
